These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 3471009

  • 21. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [Abstract] [Full Text] [Related]

  • 22. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A.
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [Abstract] [Full Text] [Related]

  • 23. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
    Thiele J, Kvasnicka HM.
    Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
    [Abstract] [Full Text] [Related]

  • 24. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP, Sanchez SR, Ewton AA, Rice L, Perkins SL, Dunphy CH, Chang CC.
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [Abstract] [Full Text] [Related]

  • 25. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL.
    Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
    [No Abstract] [Full Text] [Related]

  • 26. The bone marrow in myeloproliferative and dysmyelopoietic syndromes.
    Wolf BC, Neiman RS.
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):669-94. PubMed ID: 3065324
    [Abstract] [Full Text] [Related]

  • 27. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
    Tovar-Bobadilla JL, Ortiz-Hidalgo C.
    Gac Med Mex; 2016 Dec; 152(3):407-18. PubMed ID: 27335198
    [Abstract] [Full Text] [Related]

  • 28. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
    Buhr T, Georgii A, Choritz H.
    Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
    [Abstract] [Full Text] [Related]

  • 29. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
    Bartl R, Frisch B, Hoffmann-Fezer G, Burkhardt R.
    Haematologia (Budap); 1984 Mar; 17(2):227-46. PubMed ID: 6534830
    [Abstract] [Full Text] [Related]

  • 30. [Value of Beckenkamm histobiopsy in the diagnosis of malignant lymphoma infiltrates in bone marrow].
    Günther C, Helbig W, Püschel W, Hofmann FA.
    Z Gesamte Inn Med; 1982 Jul 15; 37(14):445-53. PubMed ID: 7136088
    [Abstract] [Full Text] [Related]

  • 31. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
    Frisch B, Bartl R, Burkhardt R, Jäger K.
    Haematologia (Budap); 1984 Jul 15; 17(2):209-26. PubMed ID: 6534829
    [Abstract] [Full Text] [Related]

  • 32. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K.
    Eur J Haematol; 2004 Jun 15; 72(6):410-5. PubMed ID: 15128419
    [Abstract] [Full Text] [Related]

  • 33. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look.
    Ebie N, Loew JM, Gregory SA.
    Hematol Pathol; 1989 Jun 15; 3(1):29-33. PubMed ID: 2745358
    [Abstract] [Full Text] [Related]

  • 34. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
    Kreft A, Büche G, Ghalibafian M, Buhr T, Fischer T, Kirkpatrick CJ.
    Acta Haematol; 2005 Jun 15; 113(2):137-43. PubMed ID: 15802893
    [Abstract] [Full Text] [Related]

  • 35. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
    Ferrero D, Tarella C, Pregno P, Pileri A, Gallo E.
    Cancer Res; 1986 Feb 15; 46(2):975-80. PubMed ID: 3455679
    [Abstract] [Full Text] [Related]

  • 36. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R, Frisch B, Wilmanns W.
    Eur J Haematol; 1993 Jan 15; 50(1):41-52. PubMed ID: 8436214
    [Abstract] [Full Text] [Related]

  • 37. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.
    Georgii A, Buhr T, Buesche G, Kreft A, Choritz H.
    Leuk Lymphoma; 1996 Sep 15; 22 Suppl 1():15-29. PubMed ID: 8951769
    [Abstract] [Full Text] [Related]

  • 38. Incidence of 'dry tap' on bone marrow aspirations in lymphomas and carcinomas. Diagnostic value of the small material in the needle.
    Engeset A, Nesheim A, Sokolowski J.
    Scand J Haematol; 1979 May 15; 22(5):417-22. PubMed ID: 382344
    [Abstract] [Full Text] [Related]

  • 39. The value of bone marrow biopsy in chronic myeloid leukaemia.
    Seewann HL, Lehnert M, Jüttner F.
    Haematologia (Budap); 1983 May 15; 16(1-4):67-72. PubMed ID: 6592124
    [Abstract] [Full Text] [Related]

  • 40. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.
    Florena AM, Tripodo C, Iannitto E, Porcasi R, Ingrao S, Franco V.
    Haematologica; 2004 Aug 15; 89(8):911-9. PubMed ID: 15339673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.